{"name":"Helicore Biopharma, Inc.","slug":"helicore-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBjdUI1el80aHJwMFNwUzFqUEkwNjVtNm9zd3BsV2ZOQ243Zk1hMV9pZlZOVjJzaGFwSHR5N0R2Q3l3d21Nd3JRNDhyTUJiUzJsWWdF?oc=5","date":"2025-12-02","type":"pipeline","source":"FirstWord Pharma","summary":"Weight-loss updates from Fractyl, Helicore, plus Tizania's IL-6 spinout plans - FirstWord Pharma","headline":"Weight-loss updates from Fractyl, Helicore, plus Tizania's IL-6 spinout plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOZUFZQTg3Zi1pbFV2cjBuX0k0RWs0YV83bnBMNTV3NktIWlIyZDR5NjJCU1pNenpKemRsM2loWWlDYWMtUURlWHFfeDFjMHVPN2RpUjRwSW81S0hjM2taVVdBNHl0NTg0MWp6bWs2QnZzUjJfV0xWcFFtdFUtdF81MFJMMGJ3VGJmNFVHaVNPcHM1aXA0NWZnLQ?oc=5","date":"2025-03-24","type":"pipeline","source":"Pharma Voice","summary":"Biotechs emerging from stealth take aim at pharma’s prime targets - Pharma Voice","headline":"Biotechs emerging from stealth take aim at pharma’s prime targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE05LWlRM3prTlRyWExCbWllYnhxQlVKSmExQ3lxMXhqVXFkemYwNEFIcG5VT3hKejh6c0NrUHdXU3YzUy1jVjhzSjBhdzJKZVE0QzRvc3AzbnZEOGpBVnZB?oc=5","date":"2025-01-31","type":"pipeline","source":"The Pharma Letter","summary":"Helicore Biopharma - The Pharma Letter","headline":"Helicore Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOTzhOaThEYVhRUzBjMEpLR25vQkRPa0I5aW9sRS1FeHFlT2NDSTVlZmZNb1BNY25KTHllT0ZGOTM3ejVSRVFzcGxZdWtTd3Axclh5SDZBd1B3LW9DcDRHVmNlNGZ4cUE0dEQ4UURtMzZ5WDRZN0VLbi00dWhFZXFzaTdzMjQ3SENxMHJhUUVfWmJhQ1NkT1lwS1FaRQ?oc=5","date":"2025-01-29","type":"pipeline","source":"The Pharma Letter","summary":"Another obesity contender launches, with $65 million - The Pharma Letter","headline":"Another obesity contender launches, with $65 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNWDBjWFBOWmxaNnE0MjFIcm9BNmJ4aHNvVVFBbEZNWTZrdWVCR2pMUTQxa01XcHlzUEVVeWlCUVNkb0FWdGFTeHZDejRXeEdROWZtejJwQVBoSzREMDFGc0c5TmxiSjJoOFlQVmMyb19pZ0N6QlI3Vzc5X0ltTDRuZGlTNjMyT0p5ZnFtVjRLeHVhWkdiMGc?oc=5","date":"2025-01-28","type":"pipeline","source":"BioPharma Dive","summary":"Versant invests again in obesity, this time backing Helicore Biopharma - BioPharma Dive","headline":"Versant invests again in obesity, this time backing Helicore Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQWFZ0dmltMmthRFY0MXhkejAtenRHa19YR1J3VTNnQkM2VnBIb3JpWGlYYWxpMlUxb29LTEg0M2ZGczZ3Wl9jZzlnVG9oejRBcUJ0UUdwSlRGM1dWME1WYlRxcTd4UGd4OWVhRmhIN2JScFZqT1JwcEkzWlRaWm1tRmJURTJiUmg2Zk9tamI2TVlEMmxtTXJNMTIwajZ2Vi1RV2RLVmNHWUxQUkZzZGVKNG1jbF9NWjFJdVV5R3gyMHVjTWdLR3dfM3U1dHh4UzFZN1VRMUhUM0pValZpUUdpY2FCRVlvNWxZZWRSZ2M0U29aeUhxUmpNMjI4UDRHbE1WQnc3RGJCVU5nTm9xajFmdWpuSURsNHFVWWFKM0JYRlctemdqSW4za2VtQnRqOVdOcDRlVXhfQQ?oc=5","date":"2025-01-28","type":"pipeline","source":"globenewswire.com","summary":"Helicore Biopharma Emerges from Stealth to Continue - globenewswire.com","headline":"Helicore Biopharma Emerges from Stealth to Continue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNEtvUEl4eERiX21DY010a3VpZUNpdU5wLTl6UHlfaFZtaGxlSjFIcVppSWFYR295SnBBV0lhOTJGUlpEMUR6UmJwMVk1ZlE1UjZhUG1PcHEwMjVZNllyLXE1eE91dWd1ak04VE51QlJrdHlLNUN3VG5vdHcyamNiMlRxdVJRZ0JFMnVsZjUxYzg3c2JwbzlnTTlFTjlmRFFWSkQ4YWUySkNCTFRDTkxuOEVzRFhzRXlUVmVn?oc=5","date":"2025-01-28","type":"pipeline","source":"Fierce Biotech","summary":"Versant launches another obesity biotech with $65M series A and 'clinic-ready' GIP antibody - Fierce Biotech","headline":"Versant launches another obesity biotech with $65M series A and 'clinic-ready' GIP antibody","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1RS0FrZFV4bUhCWmY1Tm13UUYyYV8xRHI4WWV2NnFnS0dYejZEV1Z5VXhSVHM3ZEkyaGxCSk1ianI2ZzZFZ29EUnpLcThhQlZfS3cw?oc=5","date":"2025-01-28","type":"pipeline","source":"FirstWord Pharma","summary":"Helicore joins the Versant obesity stable with novel GIP antagonist - FirstWord Pharma","headline":"Helicore joins the Versant obesity stable with novel GIP antagonist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOWTM0WWM0eXRFTG9xSlQyejhYYnVMU3JRdVN2cmYwX1RhLWExMmxROVVEaklDRGwwNlNjWktiOWFRSC03OGd5Z0pQYklvODdyUWowUkprTlVxSFJ0UHJkSml2azVfVkhqNjJPQlM5XzlKZE5aSXJBTjFIZ0t4Tlh1M0JUMHpFbXdaYUFRaUVGZ0tRY2VycGRRSmhDTW8tZG01a2RXbw?oc=5","date":"2023-11-08","type":"deal","source":"The Business Journals","summary":"Deal reached to sell some assets of bankrupt Raleigh firm - The Business Journals","headline":"Deal reached to sell some assets of bankrupt Raleigh firm","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}